MedTrace Logo

Effect of Vitamin d and Omega 3 on Osteocalcin

NCT04005612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-07-14

No results posted yet for this study

Summary

Assessing the combined effect of omega-3 fatty acid and vitamin D 3 on plasma osteocalcin levels

Conditions

  • Vitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

vitamin D3

50,000 IU VD3 / week for 8 weeks

DIETARY_SUPPLEMENT

omega-3 fatty acid

300 mg of omega 3-FA once daily for 8 weeks

DIETARY_SUPPLEMENT

vitamin D3 and omega-3 fatty acid

50,000 IU VD3 / week for 8 weeks and 300 mg of omega-3FA once daily for 8 weeks

OTHER

control

no intervention

Sponsors & Collaborators

  • Applied Science Private University

    lead OTHER

Principal Investigators

  • Mahmoud S Abu-Samak, PhD · Applied Science Private University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-02-01
Completion
2020-02-01

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04005612 on ClinicalTrials.gov